Lrp1 is a host entry factor for Rift Valley fever virus is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 138 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
St. Jude Children's Research Hospital
Grant: 1K08AI144033
St. Jude Children's Research Hospital
Grant: P01AI120943
St. Jude Children's Research Hospital
Grant: P41GM103422
St. Jude Children's Research Hospital
Grant: R01AI107056
St. Jude Children's Research Hospital
Grant: R01AI123926
St. Jude Children's Research Hospital
Grant: R01AI130152
St. Jude Children's Research Hospital
Grant: R01AI161765
St. Jude Children's Research Hospital
Grant: R01NS101100
St. Jude Children's Research Hospital
Grant: R24GM136766
St. Jude Children's Research Hospital
Grant: R37 AI059371
St. Jude Children's Research Hospital
Grant: T32AI060525
St. Jude Children's Research Hospital
Grant: T32AI106688
St. Jude Children's Research Hospital
Grant: U19AI10972505
St. Jude Children's Research Hospital
Grant: U19AI142784
St. Jude Children's Research Hospital
Grant: AARG-16-441560
NIAID NIH HHS
Grant: K08 AI144033
NIAID NIH HHS
Grant: R21 AI163603
NIAID NIH HHS
Grant: R01 AI143292
NIAID NIH HHS
Grant: R01 AI150792
FWCI
5.64
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection
Additional file 1 of Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection